Integrated Analysis Identifies an Immune-Based Prognostic Signature for the Mesenchymal Identity in Gastric Cancer

<div>Pathway alternation between the two immune-risk groups. (a) Gene ontology (GO) of the upexpressed genes between the high- and low-immune-risk groups. (b) Gene Set Enrichment Analysis (GSEA) between the high- and low-immune-risk groups.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Integrated Analysis Identifies an Immune-Based Prognostic Signature for the Mesenchymal Identity in Gastric Cancer 